Title: | Manufacturing of dry powder injection of Ceftriaxone 1000 mg USP |
Authors: | Raja, Nirali H. |
Issue Date: | 5-Apr-2023 |
Citation: | Raja, Nirali H. (2022-23). Manufacturing of dry powder injection of Ceftriaxone 1000 mg USP. Department of Biotechnology Atmiya University, |
Abstract: | Pharmaceutical means which connected with the industrial production of medicines. There are different forms of medicines like oral or external, Intramuscular or Intravascular.Sanolet Lifecare Private Limited is a private company. It have parental manufacturing drugs which given direct in IM or IV. This company have manufacturing plant for beta-lactum dry powder injections. This company include different departments like production department, QC department, QA department, engineering department & packaging & storage department. As I had worked on the product named Ceftriaxone for injection USP-1000 mg. Ceftriaxone belongs to the class of medicines known as cephalosporin antibiotic under the third generation. Ceftriaxone is given as an injection, either intramuscularly or intravenously. It is used for the treatment of bacterial infections in various locations, such as in the respiratory tract, skin, soft tissue, and urinary tract. Different tests that we observed and performed like Sterility test, BET test (LAL test), environmental analysis Sterility test are done to check the quality of the product. The study of this concept is necessary for getting real time practical experience before completing the studies. In this report I had given a introduction about my internship field along with the activities which I had performed during my internship period. I also learn practical with the theoretical concepts that observed during my internship. |
URI: | http://10.9.150.37:8080/dspace//handle/atmiyauni/1190 |
Appears in Collections: | 02. Internship Report Master of Biotechnology Students |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Manufacturing of dry powder injection of Ceftriaxone 1000 mg USP.pdf | 1.14 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.